-- CD BioGlyco, a leading biotechnology company specializing in glycan-related products, today announced the launch of its specialized Lectin Production service. Designed to support global researchers, this service aims to provide high-quality, reliable lectins to facilitate breakthroughs in biomedical research, drug discovery, and diagnostics.
Lectins are a diverse group of sugar-binding proteins that play a key role in deciphering the "sugar code"—the complex glycan features on cell surfaces that control cell adhesion, immune responses, and disease progression. That's why demand for pure, active lectin products is growing rapidly in both academia and industry. However, producing these products—especially recombinant lectins—has always been challenging, mainly due to their complex folding, glycosylation, and activity-maintenance requirements.
CD BioGlyco's new offering addresses this gap by providing both natural and recombinant Lectin Products, ensuring researchers have access to the specific probes they need.
Meeting the Demand for Specialized Lectin Tools
CD BioGlyco's product portfolio covers several key areas of lectin research:
Native Lectin Production: Using homogenization, precipitation, and affinity chromatography methods, high-purity lectins are isolated from plants (e.g., garlic), as well as from animals and fungi.
Recombinant Lectin Production: To address the limitations of native extraction, CD BioGlyco offers recombinant production solutions based on bacterial, yeast, insect, and mammalian cell systems, ensuring stable activity and batch-to-batch consistency.
Custom Purification: Based on chromatography methods (gel filtration, ion exchange, affinity chromatography), impurities are removed, and product functionality is verified through advanced analytical techniques.
"Our goal is simple - to provide researchers with high-quality lectin products that save them time and effort, and deliver reliable data," said Anna, project leader at CD BioGlyco. "Whether customers need common native lectins or complex recombinant proteins, we have the means to help them see what's really going on behind glycosylation."
The Growing Importance of Lectins
Recent studies have further confirmed the importance of lectins. Scientists have successively discovered multiple novel lectins that can specifically recognize sugar chains such as LewisX and LacdiNAc—glycans that play a key role in cancer research. In addition, through engineering, researchers have successfully altered the binding specificity of lectins, paving the way for the development of new diagnostic tools.
With this lectin production service, CD BioGlyco aims to build a one-stop platform for glycobiology—helping scientists characterize exosomes, run lectin microarrays, and isolate glycoproteins more easily than before.
Availability
The Lectin Products and production services are available immediately for research and manufacturing partners worldwide. They are strictly intended for laboratory use only and are not for direct human or veterinary use.
For more information about CD BioGlyco's Lectin Production service and to view the full catalog of Lectin Products, please visit https://www.bioglyco.com/lectin-production.html
About CD BioGlyco
CD BioGlyco is a global independent biotechnology company headquartered in Shirley, NY. The company is dedicated to discovering, developing, and manufacturing innovative glycobiology solutions, including custom synthesis, glycomics, and glycoengineering, to improve research outcomes for scientists worldwide.
Contact Info:
Name: Anna Bryan
Email: Send Email
Organization: CD BioGlyco
Website: https://www.bioglyco.com/
Release ID: 89193576
Google
RSS